Objective: To describe a case of immune-mediated thrombocytopenia (IMT) after massive Africanized bee envenomation in a dog.
Case Summary: While boarding at a kennel, a dog was stung by approximately 300 Africanized bees. During initial veterinary examination, the dog was deemed to be in shock, characterized by collapse, with hypotension, bradycardia, and hypoglycemia. In addition, severe diffuse erythema and edema were noted over the entire body. Supportive care, including IV crystalloid and colloid fluids, dextrose, fresh frozen plasma, oxygen therapy, broad spectrum antimicrobials, dexamethasone, and diphenhydramine was initiated. The dog's condition stabilized over the next 2 days. Forty-eight hours after admission the dog developed hematemesis and hematochezia, and severe thrombocytopenia was identified. Extensive diagnostic investigation revealed no likely trigger other than the Africianized bee exposure, and a diagnosis of IMT was made. Following a red blood cell transfusion and immunosuppressive doses of dexamethasone and gastroprotectant therapy, the dog's condition stabilized, and the platelet count returned to normal after 7 days from initiation of therapy.
New Or Unique Information Provided: IMT is a possible sequelae of massive Africanized bee envenomation in the dog.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/vec.12120 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical and pathological findings of Africanized bee (Apis mellifera) envenomation in horses.
Toxicon
November 2024
São Paulo State University (UNESP), School of Veterinary Medicine and Animal Science, Department of Veterinary Clinical Science, Botucatu, Brazil. Electronic address:
Africanized crossbred bees (Apis mellifera) originated in Brazil in 1957, and since then, the number of accidents involving humans and animals has significantly increased. Although they are considered clinical emergencies, there are few reports describing the clinical and pathological aspects of bee envenomation in horses. In this context, this report aims to describe the clinical and pathological features of bee toxicity after massive bee envenomation in three horses.
View Article and Find Full Text PDFFatal Africanized bee attack in captive non-human primates (Saimiri ustus and Sapajus libidinosus).
Toxicon
April 2024
Veterinary Pathology and Forensic Laboratory, Veterinary Teaching Hospital, University of Brasilia, Distrito Federal, Brazil; Graduate Program in Animal Science, University of Brasilia, Distrito Federal, Brazil. Electronic address:
Bee stings (BS) are a life-threatening issue and a growing concern for public health and animals in the Americas. We describe the clinical, pathological, and ultrastructural findings of a massive lethal bee attack in two non-human primates (NHPs). Both animals showed BS scattered throughout the skin, surrounded by a local reaction, diffuse pulmonary congestion, edema, hemorrhage, and remarkable degeneration and necrosis of renal epithelial cells from the proximal and distal tubules, characterizing a systemic bee envenomation reaction.
View Article and Find Full Text PDFStandardized guidelines for Africanized honeybee venom production needed for development of new apilic antivenom.
J Toxicol Environ Health B Crit Rev
February 2024
Center for the Study of Venoms and Venomous Animals (CEVAP), São Paulo State University (UNESP), Botucatu, Brazil.
Article Synopsis
- Africanized bees have proliferated in the Americas since 1956, leading to significant human and animal fatalities, particularly in Brazil where over 100,000 incidents and 303 deaths were recorded in the past five years.
- Brazilian researchers have developed the world’s first specific antivenom for Africanized honey bee stings, successfully tested on 20 patients in a Phase 2 clinical trial.
- The antivenom's production involved a meticulous process of extracting and purifying bee venom toxins, following strict good manufacturing practices (GMP), ensuring the welfare of both bees and horses used in the serum production.
Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.
Front Immunol
September 2021
Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Botucatu Medical School (FMB), São Paulo State University (UNESP - Univ Estadual Paulista), Botucatu, Brazil.
We evaluated the safety, optimal dose, and preliminary effectiveness of a new-approach Africanized honeybee () Antivenom (AAV) in a phase I/II, multicenter, non-randomized, single-arm clinical trial involving 20 participants with multiple stings. Participants received 2 to 10 vials of AAV depending on the number of stings they suffered, or a predefined adjuvant, symptomatic, and complementary treatment. The primary safety endpoint was the occurrence of early adverse reactions within the first 24 h of treatment.
View Article and Find Full Text PDFA Novel Apilic Antivenom to Treat Massive, Africanized Honeybee Attacks: A Preclinical Study from the Lethality to Some Biochemical and Pharmacological Activities Neutralization.
Toxins (Basel)
January 2021
Graduate Program in Pharmacology and Medicinal Chemistry, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Massive, Africanized honeybee attacks have increased in Brazil over the years. Humans and animals present local and systemic effects after envenomation, and there is no specific treatment for this potentially lethal event. This study evaluated the ability of a new Apilic antivenom, which is composed of F(ab')2 fraction of specific immunoglobulins in heterologous and hyperimmune equine serum, to neutralize venom and melittin, in vitro and in vivo, in mice.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!